Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label Placebos”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03418493
What this trial is testing

LY3316531 in Healthy Participants and in Participants With Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 63
Large-scale testing (Phase 3)Study completedNCT01262456
What this trial is testing

Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients

Who this might be right for
Nocturia
Ferring Pharmaceuticals 395
Not applicableActive Not RecruitingNCT06466603
What this trial is testing

Probiotics for Anxiety Study

Who this might be right for
Anxiety
Verb Biotics LLC 122
Testing effectiveness (Phase 2)Active Not RecruitingNCT05923866
What this trial is testing

ONO-2808 in Patients With Multiple System Atrophy

Who this might be right for
Multiple System Atrophy (MSA)
Ono Pharmaceutical Co., Ltd. 92
Early research (Phase 1)Study completedNCT01762839
What this trial is testing

Assess the Cardiac Safety of Oritavancin in Healthy Participants

Who this might be right for
Healthy
Melinta Therapeutics, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT00368472
What this trial is testing

4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Inc. 138
Large-scale testing (Phase 3)Study completedNCT00226707
What this trial is testing

Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand Dermatitis

Who this might be right for
Chronic Hand Dermatitis
Novartis 652
Large-scale testing (Phase 3)Ended earlyNCT04684511
What this trial is testing

Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy

Who this might be right for
Hemophilic Arthropathy
Tremeau Pharmceuticals, Inc. 2
Testing effectiveness (Phase 2)Study completedNCT00409032
What this trial is testing

A Dose-response Study With Strontium Malonate in Postmenopausal Women

Who this might be right for
Osteoporosis
Osteologix 275
Testing effectiveness (Phase 2)Study completedNCT00872898
What this trial is testing

Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism

Who this might be right for
Autism
Forest Laboratories 124
Large-scale testing (Phase 3)Study completedNCT00717236
What this trial is testing

Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
UCB Pharma 1,648
Early research (Phase 1)Study completedNCT00902707
What this trial is testing

Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung

Who this might be right for
Mucociliary Clearance
University of North Carolina, Chapel Hill 12
Testing effectiveness (Phase 2)Study completedNCT00789035
What this trial is testing

12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 408
Early research (Phase 1)Study completedNCT01059578
What this trial is testing

First Study in Humans With GSK206136

Who this might be right for
Depressive Disorder and Anxiety Disorders
GlaxoSmithKline 33
Testing effectiveness (Phase 2)Looking for participantsNCT06680830
What this trial is testing

Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Who this might be right for
Parkinson DiseaseParkinsonIdiopathic Parkinson Disease+2 more
Neuron23 Inc. 150
Large-scale testing (Phase 3)Study completedNCT00463567
What this trial is testing

26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic ObstructiveCOPDLung Diseases, Obstructive
Novartis 2,059
Large-scale testing (Phase 3)Study completedNCT00507065
What this trial is testing

Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD)

Who this might be right for
ADHD
Shire 329
Large-scale testing (Phase 3)Looking for participantsNCT07082842
What this trial is testing

Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Sunshine Lake Pharma Co., Ltd. 472
Testing effectiveness (Phase 2)Ended earlyNCT04264442
What this trial is testing

Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
Fulcrum Therapeutics 76
Large-scale testing (Phase 3)Looking for participantsNCT06456580
What this trial is testing

Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

Who this might be right for
Generalized Myasthenia Gravis
Vor Biopharma 180
Next Page